Skip to main content
    A

    Alector Inc (ALEC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.91
    +0.03 (+1.60%)

    Market Cap: $209.91M

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    61%(19/31)
    Avg Surprise
    -22.57%
    Streak
    14 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.21
    Range$-0.24 - $-0.16
    6 analysts
    EPS RevisionsNo revisions (7d)
    2
    4
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.23+7.4%
    60d ago$-0.21+2.3%
    30d ago$-0.23+8.0%
    7d ago$-0.23+9.5%
    Current$-0.21
    Revenue Consensus
    $2M
    Range$0 - $5M
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.02
    Range$-0.21 - $0.62
    6 analysts
    Revenue Consensus
    $8M
    Range$-15123030 - $93M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.02---
    Sep 26EST
    		-$-0.21---
    Jun 26
    Reported Aug 6
    		$-0.21$-0.24+12.50%Beat+30.0%
    Mar 26
    Reported May 7
    		$-0.21$-0.27+22.22%Beat+48.8%
    Dec 25
    Reported Feb 25
    		$-0.34$-0.39+13.11%Beat-1600.0%
    Sep 25
    Reported Nov 6
    		$-0.34$-0.41+17.07%Beat+20.9%
    Jun 25
    Reported Aug 7
    		$-0.30$-0.45+33.33%Beat+25.0%
    Mar 25
    Reported May 8
    		$-0.41$-0.46+10.87%Beat-7.9%
    Dec 24
    Reported Feb 26
    		$-0.02N/A+96.33%Beat+95.9%
    Sep 24
    Reported Nov 6
    		$-0.43$-0.53+18.87%Beat+18.9%
    Jun 24
    Reported Aug 7
    		$-0.40$-0.48+16.67%Beat-2100.0%
    Mar 24
    Reported May 8
    		$-0.38$-0.49+22.45%Beat+30.9%
    Dec 23
    Reported Feb 27
    		$-0.49$-0.77+36.36%Beat+22.2%
    Sep 23
    Reported Nov 7
    		$-0.53$-0.65+18.46%Beat+5.4%
    Jun 23
    Reported Aug 3
    		$0.02N/A+102.44%Beat-83.3%
    Mar 23
    Reported May 4
    		$-0.55$-0.78+29.49%Beat-1.9%
    Dec 22
    Reported Feb 28
    		$-0.63$-0.46-36.96%Miss+7.4%
    Sep 22
    Reported Nov 8
    		$-0.56$-0.51-9.80%Miss-137.6%
    Jun 22
    Reported Aug 4
    		$0.12N/A+127.27%Beat+117.4%
    Mar 22
    Reported May 5
    		$-0.54$0.17-417.65%Miss+18.2%
    Dec 21
    Reported Feb 24
    		$-0.68$-0.19-257.89%Miss-3.0%
    Sep 21
    Reported Nov 4
    		$1.49$2.83-47.35%Miss+322.4%
    Jun 21
    Reported Aug 3
    		$-0.69$-0.69+0.00%Beat-19.0%
    Mar 21
    Reported May 5
    		$-0.66$-0.67+1.49%Beat-24.5%
    Dec 20
    Reported Feb 25
    		$-0.66$-0.66+0.00%Beat-46.7%
    Sep 20
    Reported Nov 10
    		$-0.67$-0.55-21.82%Miss-42.6%
    Jun 20
    Reported Aug 11
    		$-0.58$-0.50-16.00%Miss-61.1%
    Mar 20
    Reported May 13
    		$-0.53$-0.43-23.26%Miss-96.3%
    Dec 19
    Reported Mar 24
    		$-0.45$-0.44-2.27%Miss+69.6%
    Sep 19
    Reported Nov 12
    		$-0.47$-0.40-17.50%Miss-62.1%
    Jun 19
    Reported Aug 12
    		$-0.36$-0.32-12.50%Miss-
    Mar 19
    Reported May 13
    		$-0.27$-0.31+12.90%Beat-
    Dec 18
    Reported Feb 7
    		$-1.48$-0.28-428.57%Miss-
    Sep 18
    Reported Oct 12
    		$-0.29$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-1.74EV/EBITDAN/A
    Price/FCF-1.34xFCF Yield-74.56%
    Profitability
    Profit Margin0.00%Operating Margin-735.00%
    ROE-385.10%ROIC96357.38%
    Financial Health
    Debt/Equity-0.99xInterest CoverageN/A
    Current Ratio5.26xQuick Ratio5.26x
    Trading Statistics
    Beta0.62Avg Volume6.21M
    52-Week High$3.3352-Week Low$1.09

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.94
    SMA 20$1.93
    SMA 50$2.09
    SMA 200$2.02
    EMA 10$1.94
    EMA 20$1.96
    EMA 50$1.99
    EMA 200$1.96

    MACD

    Line: -0.04Signal: -0.04Hist: 0.01

    ADX

    ADX: 23.1+DI: 28.1-DI: 20.3

    Aroon & PSAR

    Aroon Up68.0
    Aroon Down76.0
    PSAR$2.50

    Bollinger Bands

    Upper Band$2.09
    Lower Band$1.77
    %B Position1664%(Upper)
    Band Width0.44

    RSI (14-Day)

    Neutral
    46.6

    Momentum Oscillators

    Stoch %K15.7
    Stoch %D21.7
    Williams %R-82.0
    ROC (10d)2.7%
    Momentum0.05
    CCI (20d)-40.5
    MFI (14d)83.0

    Volatility Measures

    ATR (14d)$0.20(10.5%)
    StdDev (20d)0.08
    Hist Vol75.6%(High)

    Volume Flow

    VWAP$1.90
    OBV107.0M
    AD Line-73.8M
    CMF (20d)-0.600

    Volume Metrics

    Avg Vol (20d)6.8M
    Vol Ratio0.2x(Low)
    VWMA (20d)$1.97

    Pivot Points

    R3$2.03
    R2$1.97
    R1$1.93
    Pivot Point$1.87
    S1$1.83
    S2$1.77
    S3$1.73

    Advanced Oscillators

    TSI-6.49
    Ultimate Osc49.9
    KST-101.81

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$3.32M$1.05M$6.24M$3.26M$7.87M$3.67M$54.24M$15.34M$15.08M$15.89M$15.19M$9.11M
    Cost of Revenue$0$0$2.26M$0$0$0$46.46M$0$0$0$2.26M$0
    Gross Profit$3.32M$1.05M$6.24M$3.26M$7.87M$3.67M$54.24M$15.34M$15.08M$15.89M$15.19M$9.11M
    Operating Expenses$27.71M$25.96M$45.80M$40.87M$42.01M$48.37M$61.49M$63.78M$60.69M$59.60M$62.64M$59.69M
    R&D$19.46M$17.86M$32.46M$29.35M$27.61M$33.64M$46.46M$48.00M$46.31M$45.17M$47.72M$46.33M
    SG&A$8.25M$8.11M$13.34M$11.52M$14.40M$14.73M$15.03M$15.78M$14.38M$14.43M$14.92M$13.36M
    Operating Income$-24,393,000$-24,919,000$-39,566,000$-37,608,000$-34,138,000$-44,695,000$-7,249,000$-48,434,000$-45,606,000$-43,708,000$-47,453,000$-50,583,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-22,860,000$-22,930,000$-37,099,000$-34,667,000$-30,524,000$-40,471,000$-2,026,000$-42,220,000$-38,603,000$-36,072,000$-39,768,000$-43,223,000
    Income Tax Expense$130,000$0$168,000$0$0$0$48,000$0$73,000$7,000$1.67M$1.25M
    Net Income$-22,990,000$-22,930,000$-37,267,000$-34,667,000$-30,524,000$-40,471,000$-2,074,000$-42,220,000$-38,676,000$-36,079,000$-41,434,000$-44,475,000
    EBITDA$-21,233,000$-21,435,000$-36,008,000$-33,808,000$-28,989,000$-40,581,000$-2,527,000$-43,292,000$-40,280,000$-38,360,000$-42,318,000$-45,557,000
    EBIT$-22,860,000$-22,930,000$-37,099,000$-34,667,000$-30,524,000$-40,471,000$-2,026,000$-42,220,000$-38,603,000$-36,072,000$-39,768,000$-43,223,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ALEC

    News

    H.C. Wainwright raises Alector stock price target on platform progress By Investing.com

    H.C. Wainwright increased its price target for Alector Inc. to $8.00 from $5.00, maintaining a Buy rating due to progress in its Alector Brain Carrier platform. This new target implies over 300% upside from the current...

    Investing.com Nigeria•10/15/26•Bullish

    H.C. Wainwright raises Alector stock price target on platform progress By Investing.com

    H.C. Wainwright has increased its price target for Alector Inc. (NASDAQ:ALEC) from $5.00 to $8.00, maintaining a Buy rating...

    Investing.com Canada•10/15/26•Bullish

    HC Wainwright & Co. maintains Buy rating on Alector, $8 price target

    HC Wainwright & Co. has reiterated its Buy rating on Alector's stock, setting an $8.00 price target. This target suggests a substantial 325.5% upside from the recent closing price. The firm highlighted Alector's strong...

    TradingView•10/15/26•Bullish

    Alector Price Target Raised to $8.00/Share From $5.00 by HC Wainwright & Co.

    HC Wainwright & Co. has increased its price target for Alector to $8.00 per share, up from $5.00. This adjustment reflects an updated valuation by the analyst firm for the biotechnology company.

    Moomoo•10/15/26•Bullish

    What Alector Bears Saw Before The Fall

    Alector (ALEC) shareholders experienced a 41.1% loss over the past year. Recent Q2 2026 results showed lower revenue but a narrowed loss...

    Simply Wall Street•10/15/26•Somewhat-Bearish

    ALEC Valuation and Fair Value

    P/E
    -1.7x
    Forward P/E
    8.5x
    P/FCF
    -1.3x
    P/B
    -21.3x
    See GNG's fair value

    ALEC Profitability: Margins, ROIC and FCF

    Gross margin
    100.0%
    Operating margin
    -735.0%
    Net margin
    0.0%
    ROIC
    96357.4%
    ROE
    -385.1%
    FCF margin
    -1142.6%
    FCF yield
    -74.6%

    ALEC Competitors

    CompanyTicker
    Protalix Biotherapeutics IncPLX
    ProQR Therapeutics BVPRQR
    Owens & Minor IncOMI
    Cartesian Therapeutics Inc.RNAC
    Larimar Therapeutics IncLRMR
    Pro-Dex IncPDEX
    MacroGenics IncMGNX
    Exagen IncXGN

    Sector: Healthcare

    ALEC Analyst Ratings

    Consensus
    Hold
    Analysts
    7
    Strong Buy
    0
    Buy
    3
    Hold
    2
    Sell
    1
    Strong Sell
    1

    ALEC Bull Case vs Bear Case

    Bull case

    • ALEC earns a 96357.4% return on invested capital.
    • ALEC beat EPS estimates in 100.0% of its last 8 reported quarters.

    Bear case

    • ALEC's quarterly revenue changed -57.8% year over year.

    ALEC Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    28.0%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.21
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 4 down

    Frequently Asked Questions About ALEC

    Does ALEC pay dividends?

    Alector Inc (ALEC) does not currently pay a regular dividend.

    What is ALEC's market cap?

    Alector Inc (ALEC) has a market capitalization of $209.91M with a current stock price of $1.91.

    Related stocks

    Sector: Healthcare

    All stocks starting with A

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In